Peter Shepherd: Auckland University Molecular medicine professor on Ozempic being found to reduce heart attacks

Heather du Plessis-Allan Drive

Content provided by NZME and Newstalk ZB. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by NZME and Newstalk ZB or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

14d ago 5:41

MP3•Episode home

There's been a clinical breakthrough with Hollywood's new favourite drug, which could work for more than weight loss.

Research has found semaglutide, known by brand name Ozempic, could reduce heart attack risk by 20 percent.

It also could improve cardiovascular health and reduce the risk of Alzheimer's.

But Auckland University Molecular medicine professor Peter Shepherd says it takes years of real-life usage to see the effects of a new drug.

"For a lot of people, this is really good long-term. But there is 20 - 25 percent of people who start off on this drug, and it doesn't work and they have too many side effects and they've gotta stop."

LISTEN ABOVE

See omnystudio.com/listener for privacy information.

6331 episodes

#New Zealand Current Affairs #New Zealand #NZME #Newstalk ZB #News